Eloxx Pharmaceuticals (ELOX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $13.03, -4.89% vs the prior close of $13.70.
- Volume 66.49K shares, 1.9x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELOX slides 4.9% to $13.03 on 1.9x normal volume. Closed at $13.03, -4.89% vs the prior close of $13.70. Day range $12.85–$14.11, opened at $13.83.
ELOX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ELOX slides 4.9% to $13.03 on 1.9x normal volume
- Closed at $13.03, -4.89% vs the prior close of $13.70. Day range $12.85–$14.11, opened at $13.83.
- Volume was 66.49K shares, 1.9x its 50-day average of 34.21K — unusually heavy trading.
- Price is -20.4% vs its 50-day average ($16.37).
- 52-week range $8.20–$23.40; today's close sits at 32% of that range, 44.3% below the 52-week high.
Oct 15, 2026 — ELOX jumps 12.2% to $13.70
- Closed at $13.70, +12.20% vs the prior close of $12.21. Day range $12.00–$14.24, opened at $12.24.
- Volume was 23.40K shares, 0.7x its 50-day average of 34.91K.
- Price is -16.8% vs its 50-day average ($16.47).
- 52-week range $8.20–$23.40; today's close sits at 36% of that range, 41.5% below the 52-week high.
Oct 14, 2026 — ELOX slides 3.9% to $12.21, a 1-month low
- Closed at $12.21, -3.86% vs the prior close of $12.70. Day range $12.21–$13.23, opened at $13.13.
- Volume was 12.50K shares, 0.4x its 50-day average of 35.55K — lighter than usual.
- Price is -26.2% vs its 50-day average ($16.55).
- 52-week range $8.20–$23.40; today's close sits at 26% of that range, 47.8% below the 52-week high.
Oct 13, 2026 — ELOX slides 8.6% to $12.70, a 1-month low
- Closed at $12.70, -8.57% vs the prior close of $13.89. Day range $12.00–$13.80, opened at $13.80.
- Volume was 22.50K shares, 0.6x its 50-day average of 36.42K.
- Price is -23.8% vs its 50-day average ($16.67).
- 52-week range $8.20–$23.40; today's close sits at 30% of that range, 45.7% below the 52-week high.
Oct 12, 2026 — ELOX rises 1.1% to $13.89
- Closed at $13.89, +1.09% vs the prior close of $13.74. Day range $13.82–$14.62, opened at $14.01.
- Volume was 26.10K shares, 0.7x its 50-day average of 36.96K.
- Price is -17.3% vs its 50-day average ($16.79).
- 52-week range $8.20–$23.40; today's close sits at 37% of that range, 40.6% below the 52-week high.
Oct 9, 2026 — ELOX slides 9.5% to $13.74, a 1-month low
- Closed at $13.74, -9.49% vs the prior close of $15.18. Day range $13.21–$15.29, opened at $15.02.
- Volume was 31.30K shares, 0.9x its 50-day average of 36.71K.
- Price is -18.5% vs its 50-day average ($16.86).
- 52-week range $8.20–$23.40; today's close sits at 36% of that range, 41.3% below the 52-week high.
Oct 8, 2026 — ELOX rises 2.0% to $15.18
- Closed at $15.18, +2.02% vs the prior close of $14.88. Day range $14.67–$15.51, opened at $14.67.
- Volume was 10.50K shares, 0.3x its 50-day average of 37.57K — lighter than usual.
- Price is -9.9% vs its 50-day average ($16.85).
- 52-week range $8.20–$23.40; today's close sits at 46% of that range, 35.1% below the 52-week high.
Oct 7, 2026 — ELOX dips 1.7% to $14.88, a 1-month low, 4 down days in a row
- Closed at $14.88, -1.65% vs the prior close of $15.13. Day range $14.72–$15.72, opened at $15.27.
- Volume was 14.60K shares, 0.4x its 50-day average of 37.73K — lighter than usual.
- Price is -11.4% vs its 50-day average ($16.79).
- 52-week range $8.20–$23.40; today's close sits at 44% of that range, 36.4% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — ELOX dips 1.8% to $15.13, 3 down days in a row
- Closed at $15.13, -1.82% vs the prior close of $15.41. Day range $14.50–$16.02, opened at $15.34.
- Volume was 61.30K shares, 1.5x its 50-day average of 41.27K.
- Price is -9.7% vs its 50-day average ($16.75).
- 52-week range $8.20–$23.40; today's close sits at 46% of that range, 35.3% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — ELOX dips 0.6% to $15.41
- Closed at $15.41, -0.64% vs the prior close of $15.51. Day range $15.25–$16.81, opened at $15.25.
- Volume was 26.10K shares, 0.6x its 50-day average of 42.61K.
- Price is -7.7% vs its 50-day average ($16.69).
- 52-week range $8.20–$23.40; today's close sits at 47% of that range, 34.1% below the 52-week high.
Oct 2, 2026 — ELOX dips 1.3% to $15.51
- Closed at $15.51, -1.27% vs the prior close of $15.71. Day range $14.91–$16.02, opened at $15.92.
- Volume was 17.70K shares, 0.4x its 50-day average of 42.99K — lighter than usual.
- Price is -6.7% vs its 50-day average ($16.62).
- 52-week range $8.20–$23.40; today's close sits at 48% of that range, 33.7% below the 52-week high.
ELOX latest news & SEC filings
Every SEC filing by or about ELOX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 18, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 11, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.50M (prior year -$1.89M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.66 (prior year -$5.45) (loss narrowed vs Jun 30, 2025)
Jul 27, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ELOX
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: Nov 13, 2023, May 16, 2023, Apr 3, 2023. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.77% (largest 12.2%). That is a volatile stock.
- Liquidity: about 23.76K shares (≈$309.59K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $13.03 vs a range of $8.20–$23.40 (32% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 11, 2026; 8-K Jun 1, 2026.
- Share count: 4.04M shares outstanding (Aug 7, 2026), +28.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ELOX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 13.83 | 14.11 | 12.85 | 13.03 | 66.49K |
| Oct 15, 2026 | 12.24 | 14.24 | 12.00 | 13.70 | 23.40K |
| Oct 14, 2026 | 13.13 | 13.23 | 12.21 | 12.21 | 12.50K |
| Oct 13, 2026 | 13.80 | 13.80 | 12.00 | 12.70 | 22.50K |
| Oct 12, 2026 | 14.01 | 14.62 | 13.82 | 13.89 | 26.10K |
| Oct 9, 2026 | 15.02 | 15.29 | 13.21 | 13.74 | 31.30K |
| Oct 8, 2026 | 14.67 | 15.51 | 14.67 | 15.18 | 10.50K |
| Oct 7, 2026 | 15.27 | 15.72 | 14.72 | 14.88 | 14.60K |
| Oct 6, 2026 | 15.34 | 16.02 | 14.50 | 15.13 | 61.30K |
| Oct 5, 2026 | 15.25 | 16.81 | 15.25 | 15.41 | 26.10K |
| Oct 2, 2026 | 15.92 | 16.02 | 14.91 | 15.51 | 17.70K |
| Oct 1, 2026 | 15.22 | 16.30 | 15.22 | 15.71 | 10.90K |
| Sep 30, 2026 | 14.94 | 15.71 | 14.42 | 15.31 | 14.30K |
| Sep 29, 2026 | 15.41 | 15.45 | 14.79 | 15.42 | 6.10K |
| Sep 28, 2026 | 15.69 | 15.69 | 14.35 | 15.00 | 16.40K |
| Sep 25, 2026 | 15.95 | 16.36 | 14.04 | 15.03 | 27.60K |
| Sep 24, 2026 | 16.65 | 16.71 | 15.60 | 16.00 | 28.90K |
| Sep 23, 2026 | 16.56 | 16.56 | 14.50 | 15.44 | 20.30K |
| Sep 22, 2026 | 17.01 | 17.58 | 16.43 | 16.73 | 15.80K |
| Sep 21, 2026 | 17.36 | 18.25 | 17.06 | 17.19 | 22.40K |
About Eloxx Pharmaceuticals
Eloxx Pharmaceuticals (ELOX) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in ARLINGTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1035354.
ELOX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sumit Aggarwal | President and CEO | Jun 10, 2026 |
| Nina S Kjellson | Director | Jun 10, 2026 |
| Steven D Rubin | Director | Jun 10, 2026 |
| Alan Edmund Walts | Director | Jun 10, 2026 |
| Stephen W Webster | Director | Jun 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sumit Aggarwal | President and CEO | Jun 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
ELOX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-6.00M | -0.49 | $-6.33M |
| Dec 31, 2024 | $6.36M | $-3.14M | -0.84 | $-4.71M |
| Dec 31, 2023 | $0 | $-17.05M | -6.63 | $-14.34M |
| Dec 31, 2022 | — | $-36.06M | -16.65 | $-31.84M |
| Dec 31, 2021 | — | $-66.73M | -38.15 | $-35.00M |
Latest balance sheet: total assets $63.39M, total liabilities $17.18M, cash $61.96M (as of Jun 30, 2026).
ELOX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $19.18 |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| May 16, 2023 | 8-K Item 2.02 (results) | — |
| Apr 3, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Aug 15, 2022 | 8-K Item 2.02 (results) | — |
| May 10, 2022 | 8-K Item 2.02 (results) | — |
| Apr 4, 2022 | 8-K Item 2.02 (results) | — |
| Nov 9, 2021 | 8-K Item 2.02 (results) | — |
| Aug 17, 2021 | 8-K Item 2.02 (results) | — |
| May 7, 2021 | 8-K Item 2.02 (results) | — |
| Mar 11, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ELOX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.